MedPath

The Impact of Anesthesia on the Absorption of Glycine in Operative Hysteroscopy: a Randomized Controlled Trial

Not Applicable
Completed
Conditions
The Absorption of Glycine in Operative Hysteroscopy
Interventions
Procedure: General anesthesia
Procedure: Local anesthesia with sedation
Registration Number
NCT01124383
Lead Sponsor
CHU de Quebec-Universite Laval
Brief Summary

This study aimed to compare two types of anesthesia (general anesthesia and local anesthesia with sedation) on the absorption of glycine in operative hysteroscopy.

Detailed Description

As a minimally invasive procedure, operative hysteroscopy has gained popularity in the past two decades and became a standard surgical treatment for abnormal uterine bleeding unresponsive to medical management. Despite its increasing use, little information is known on the predictors of its potential complications. The absorption of glycine has been reported as the most common complication of this procedure and it remains an unpredictable complication that may lead to life-threatening conditions.

This randomized controlled trial is conducted in two centers: a tertiary care center and in a community hospital over a period of 18 months. This study aimed to compare two types of anesthesia on the absorption of glycine in operative hysteroscopy. Eligible patients undergoing operative hysteroscopy for abnormal uterine bleeding are randomized in two groups: group general anesthesia and group local anesthesia with sedation.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
95
Inclusion Criteria
  • Abnormal uterine bleeding with clinical indication for operative hysteroscopy according to an obstetrician-gynecologist.
  • American Society of Anesthesia (ASA) class 1 or 2
Exclusion Criteria
  • Any contraindications to hysteroscopy (suspicion of pelvic or vaginal-cervical infection, severe hemorrhage, pregnancy, suspicion of neoplasia and previous uterine perforation)
  • ASA class 3 or more
  • Women who had a previous endometrial resection
  • Diabetic patients
  • Women requiring a predetermined type of anesthesia because of a specific medical condition

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
General anesthesiaGeneral anesthesia-
Local anesthesia with sedationLocal anesthesia with sedation-
Primary Outcome Measures
NameTimeMethod
Median absorption of glycine (10th-90th centile)The absorption of glycine is measured between time of the introduction of the resectoscope and its final withdrawal. Assessed between 1 minute and 20 minutes after the end of surgery

The primary outcome is the median absorption of glycine (10th-90th centile). The glycine absorption is measured by an automated surgical irrigator (tandem canister: Equimat and Endomat; Karl Storz Endoscopy, Tuttlingen, Germany) and it represent the difference between the input and the output of glycine used for the irrigation of the uterine cavity.

Secondary Outcome Measures
NameTimeMethod
Patient's satisfaction towards the type of anesthesiaAssessed on postoperative day one. In average 24 hours after surgery.

Patient's satisfaction toward their anesthesia was evaluated by the following yes or no question: "If you had to undergo the same surgery, would you choose the same type of anesthesia?".

Absorption of glycine greater than 1000 mLThe absorption of glycine is measured between time of the introduction of the resectoscope and its final withdrawal. Assessed between 1 minute and 20 minutes after the end of surgery

The total absorption of glycine is measured by an automated surgical irrigator (tandem canister: Equimat and Endomat; Karl Storz Endoscopy, Tuttlingen, Germany).

Discontinuation of surgery because of excessive absorption.Assessed between 1 minute and 20 minutes after the end of surgery

Left at the discretion of the surgeon and anesthesiologist. However, according to the guidelines of the ACOG and the AAGL, it is recommended to stop the surgery when the glycine deficit exceeds 1000-1500 mL. Therefore, the surgeon who is blinded to the absorption rate will be informed when it reachs 500 and 1000 mL.

Difference of natremia pre and post-procedureAssessed the same day of surgery (no more than 6 hours after surgery)

In the hour preceeding the surgery and in the hour following surgery, natremia will be measured in the patient serum.

Postoperative severe hyponatremiaAssessed the same day of surgery (no more than 6 hours after surgery)

Defined as a patient's natremia below 125 meq/L in the first postoperative hour.

Quality of life and recoveryAssessed on postoperative day one. In average 24 hours after surgery.

8-item Short-Form Health Survey (SF-8) standardized questionnaire

Trial Locations

Locations (1)

Centre Hospitalier Universitaire de Québec

🇨🇦

Québec, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath